Column

Fighting The New Coronavirus

China-made Covid-19 vaccine expected to be available by end of Dec and costs less than $144 for two doses
China National Pharmaceutical Group (Sinopharm) chairman Liu Jingzhen said its inactivated coronavirus vaccine will be ready for approval after phase III clinical trials and is expected to be on the market by the end of December this year.
China's first new coronavirus mRNA vaccine approved to start clinical trials
The new coronavirus mRNA vaccine candidate (ARCoV) developed by the Institute of Military Medical Sciences of the Chinese Academy of Military Sciences has been approved for clinical trials, which is the first mRNA vaccine approved for clinical trials in China.
Another recombinant protein vaccine for coronavirus from China has entered clinical trials
Recently, the coronavirus recombinant protein vaccine, jointly developed by the Institute of Microbiology of the Chinese Academy of Sciences and Anhui Zhifei LongKema Biopharmaceutical Co.
China sees another inactivated novel coronavirus vaccine that has big potential
An inactivated novel coronavirus vaccine called BBIBP-CorV from a Chinese team has shown great potential in animal studies.
BYD N95 masks finally certified, will supply 150 million to California
California Governor Gavin Newsom announced on June 8 that the BYD N95 masks have obtained the National Institute for Occupational Safety and Health (NIOSH) certification, BYD will continue to supply N95 masks to California.
Another China-made nucleic acid test kit authorized for emergency use in U.S.
Beijing-based Genetron Health's novel coronavirus kit receives U.S. EUA approval after receiving CE mark in the European Union
World's first coronavirus-neutralizing antibody from Chinese team enters clinical trial
The recombinant human anti-new coronavirus monoclonal antibody injection (JS016) developed by a Chinese team has been approved by the State Drug Administration (SFDA) to enter Phase I clinical trials.
China's first Covid-19 therapeutic antibody drug approved for clinical trial
Recently, Yan Jinghua's team at the Institute of Microbiology, Chinese Academy of Sciences, developed a new fully humanized monoclonal antibody against coronavirus, which was approved for clinical trials, according to the Beijing Daily.
First coronavirus neutralizing antibody kit can detect whether the body is immune in 1 hour
Whether the body has developed immunity to the new coronavirus, the results can be obtained within an hour after testing with this kit.
Samsung launches smartwatch app to help users develop hand-washing habits
Washing your hands has always been an important way to prevent the spread of viruses, but with the COVID-19 pandemic, it's more important than ever to get into the habit.